[Intensive hospital monitoring of Shuxuening injection in 30 209 cases].

Jiang, Jun-Jie; Xie, Yan-Ming; Zhang, Yin; Li, Ming-Quan; Zhao, Yu-Bin; Wen, Ze-Huai; Li, Xue-Lin; Yi, Dan-Hui; Zhang, Yi-Kai

Jiang, Jun-Jie; Xie, Yan-Ming; Zhang, Yin; Li, Ming-Quan; Zhao, Yu-Bin; Wen, Ze-Huai; Li, Xue-Lin; Yi, Dan-Hui; Zhang, Yi-Kai.

Afiliação

Jiang JJ; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Xie YM; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhang Y; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Li MQ; Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130618, China.
Zhao YB; Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang 052560, China.
Wen ZH; Guangdong Province Traditional Chinese Medical Hospital, Guangzhou 511740, China.
Li XL; The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 452486, China.
Yi DH; Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130618, China.
Zhang YK; College of Statistics, Renmin University of China, Beijing 100872, China.

Zhongguo Zhong Yao Za Zhi ; 42(15): 2883-2888, 2017 Aug.

Article em Zh | MEDLINE | ID: mdl-29139252

Assuntos

Medicamentos de Ervas Chinesas/efeitos adversos; Vigilância de Produtos Comercializados; Humanos; Injeções

Palavras-chave

Shuxuening injection; adverse reactions; intensive hospital monitoring; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vigilância de Produtos Comercializados / Medicamentos de Ervas Chinesas Tipo de estudo: Clinical_trials Limite: Humans Idioma: Zh Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google